1747-53-1 Usage
Description
2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid ethyl ester is a chemical compound characterized by the molecular formula C9H12N2O4. It is an ethyl ester derivative of 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid, typically appearing as a white to off-white powder. 2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid ethyl ester is soluble in organic solvents and exhibits a strong odor. It serves as a crucial intermediate in the synthesis of pharmaceutical compounds, playing a significant role in research and development within the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid ethyl ester is used as a synthetic intermediate for the development of various pharmaceutical compounds. Its role in the synthesis of drugs and active pharmaceutical ingredients is vital, contributing to the creation of novel treatments and medications.
Used in Research and Development Applications:
In the realm of scientific research, this compound is utilized for research and development purposes. It aids chemists and pharmaceutical researchers in exploring new chemical pathways and understanding the properties of related compounds, which can lead to advancements in drug discovery and medicinal chemistry.
Safety Considerations:
It is important to handle 2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid ethyl ester with care due to its potential harmful effects if ingested, inhaled, or absorbed through the skin. Proper safety measures should be implemented during its use to minimize health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 1747-53-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,4 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1747-53:
(6*1)+(5*7)+(4*4)+(3*7)+(2*5)+(1*3)=91
91 % 10 = 1
So 1747-53-1 is a valid CAS Registry Number.
1747-53-1Relevant articles and documents
Synthesis of orotic acid derivatives and their effects on stem cell proliferation
Al-Obaid, Abdulrahman M.,Alfayez, Musaad,Bari, Ahmed,Betz, Richard,Ghadeer, Abdulrahman,Hosten, Eric C.,Mahmood, Amer,Syed, Saeed Ali
, p. 620 - 627 (2020)
-
3-METHYL-2- ( (2S) -2- (4- (3-METHYL-L, 2, 4-0XADIAZ0L-5-YL) PHENYL) MORPHOLINO) -6- (PYRIMIDIN-4-YL) PYRIMIDIN-4 (3H) -ONE AS TAU PROTEIN KINASE INHIBITOR
-
Page/Page column 10; 11, (2009/04/25)
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g.
INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
-
Page/Page column 90-91, (2008/06/13)
The present invention relates to a production method of an optically active morpholine compound represented by the formula 10, which includes the following steps: wherein each symbol is as defined in the specification. The present invention also relates t
